(NewsDirect)
Emergent HealthCorp. (OTC: EMGE) , a curator, developer, and marketer ofproducts in the Regenerative Health Space announced that it hasexecuted a Term Sheet and Engagement Letter with Boustead Securitiesto roll up its subsidiary Evolutionary Biologics and otherregenerative medicine and regenerative biologic products companieswith NO DILUTION to the Emergent Shareholders with a planned $10million initial capital raise and public offering and application forlisting on NASDAQ or NYSE/AMEX. Emergent’s subsidiary, EvolutionaryBiologics, and the new brand called Maximus Men’s Health, along withJuventix Regenerative Medical and Interactive Practice Solutions andNanosthetic.
Subsequent to the IPO, Emergent plans to distribute the sharesreceived by Emergent from the sale of Evolutionary Biologics as adividend to its shareholders, pro rata at NO COST to the EmergentShareholders. Such a dividend would only occur after Emergent files aRegistration Statement with the SEC and it is declared effective. Anypotential taxable event resulting from such a dividend would be theresponsibility of each individual shareholder, and Emergent adviseseach shareholder to consult with their professional advisors, andmakes no representation as to the taxable or nontaxable event. EvolutionaryBiologics , is a new kind of biologics company founded for aclear purpose: bring cutting edge regenerative products to the medicalcommunity. Emergent does not claim any of its products are approved bythe FDA to diagnose, treat, cure or prevent any disease.
Jim Morrison, formerL'Oréal President and Emergent’s full time CEO stated,“Boustead Securities is a world class financial organization. Theyapproached us to participate in rolling up a series of regenerativebiologics into a brand-new IPO. When you look at the effect that thistransaction, and the previously announced PharmaZu transaction, willhave on EMGE, it's amazing. We see this as a great way to maximizevaluation for our Company and take EMGE to the next level.”
ABOUT EMERGENT HEALTHCORPORATION
Emergent curates, develops and sells products in theRegenerative Health Space. Its products comprise of ingestibles aswell as topicals for the whole family. The company distributes itsproducts online and through Content Based Shopping using Influencersto position products in their produced content throughout the UnitedStates and Internationally. Its subsidiaries; PharmaZu , is a pure play,e-commerce products and service provider focused on the Pet Community,Pet Pharmacy and Pet Wellness using Influencers and their content,including the pet pharmacy, vet telehealth and pet wellnessbusinesses. EvolutionaryBiologics , is a new kind of biologics company founded for a clearpurpose: bring cutting edge regenerative products to the medicalcommunity. Emergent does not claim any of its products are approved bythe FDA to diagnose, treat, cure or prevent any disease. For moreinformation, please visit Emergent's Website and Social Mediaon .
Before usingany products, you should always consult with your Veterinarian and/orFamily Doctor.
SAFE HARBOR STATEMENT
This press release contains forward-lookingstatements that can be identified by terminology such as“believes,” “expects,” “potential,” “plans,”“suggests,” “may,” “should,” “could,” “intends,”or similar expressions. Many forward-looking statements involve knownand unknown risks, uncertainties and other factors that may causeactual results to be materially different from any future resultsimplied by such statements. These factors include, but are not limitedto, our ability to continue to enhance our products and systems toaddress industry changes, our ability to expand our customer base andretain existing customers, our ability to effectively compete in ourmarket segment, the lack of public information on our company, ourability to raise sufficient capital to fund our business, operations,our ability to continue as a going concern, and a limited publicmarket for our common stock, among other risks. Many factors aredifficult to predict accurately and are generally beyond thecompany's control. Forward-looking statements speak only as to thedate they are made, and we do not undertake to update forward-lookingstatements to reflect circumstances or events that occur after thedate the forward-looking statements are made.
FOR MORE INFORMATION,PLEASE CONTACT:
Jim Morrison, CEO
Emergent HealthCorporation Website
info@emergenthealthcompany.com
ContactDetails
Emergent Health Corp.
info@emergenthealthcompany.com
CompanyWebsite
https://emergenthealthcompany.com/
Copyright (c) 2023 TheNewswire - All rights reserved.